Поиск
Закладки
Озвучить текст Озвучить книгу
Изменить режим чтения
Изменить размер шрифта
Оглавление
Для озвучивания и цитирования книги перейдите в режим постраничного просмотра.
Периоперационное ведение пациентов с зависимостью от алкоголя

Список литературы

  1. Schwartz A., Knez D. Anestesia and Alcohol Addiction. In: Bryson E.O., Frost E.A.M. Perioperative Addiction. Clinical Management of the Addicted Patient. Shringer Science+Business Media, LLC, 2012 – 290 p.
  2. Анохина И.П. Основные биологические механизмы зависимости от психоактивных веществ. В кн.: Наркология: национальное руководство/ Под ред. Иванца Н.Н., Анохиной И.П., Винниковой М.А. – М. ГОЭТАР-Медиа, 2008. – 720 с.
  3. Киржанова В.В., Григорова Н.И., Киржанов В.Н., Сидорюк О.В. Основные показатели деятельности наркологической службы в Российской Федерации в 2014-2015 годах: Статистический сборник. – М.: ФГБУ «ФМИЦПН им. В.П. Сербского» Минздрава России, 2016. – 182 с. Доступ по http://www.nncn.ru/2_842.html.
  4. Кошкина Е.А., Киржанова В.В. Эпидемиология наркологических заболеваний. В кн.: Наркология: национальное руководство/ Под ред. Иванца Н.Н., Анохиной И.П., Винниковой М.А. – М. ГОЭТАР-Медиа, 2008. – 720 с.
  5. Holt S.R., Ramos J., Harma M.A., Cabrera F., Louis-Ashby C., Dinh A., Tetrault J.M., Fiellin D.A. Prevalence of unhealthy substance use on teaching and hospitalist medical services: implications for education. Am J Addict 2012; 21:111–119.
  6. Smothers B.A., Yahr H.T., Ruhl C.E. Detection of alcohol use disorders in general hospital admissions in the United States. Arch Intern Med 2004; 164:749–756.
  7. Saitz R., Freedner N., Palfai T.P., Horton N.J., Samet J.H. The severity of unhealthy alcohol use in hospitalized medical patients. The spectrum is narrow. Journal of General Internal Medicine 2006; 21:381–385.
  8. Freyer-Adam J., Coder B., Baumeister S.E., Bischof G., Riedel J., Paatsch K., Wedler B., Rumpf H.J., John U., Hapke U. Brief alcohol intervention for general hospital inpatients: a randomized controlled trial. Drug Alcohol Depend 2008; 93:233–243.
  9. Spies C.D., Kip M.J., Neumann T. et al., New strategies to detect alcohol use disorders in the preoperative assessment clinic of a german university hospital. Anesthesiology 2008; 109 (2):171– 179.
  10. Альтшулер В.Б. (с участием Чирко В.В., Рохлиной М.Л.). Общая психопатология наркологических заболеваний. В кн.: Наркология: национальное руководство/ Под ред. Иванца Н.Н., Анохиной И.П., Винниковой М.А. – М. ГОЭТАР-Медиа, 2008. – 720 с.
  11. Roche A.M., Freeman T., Skinner N. From data to evidence, to action: findings from a systematic review of hospital screening studies for high risk alcohol consumption. Drug Alcohol Depend 2006; 83:1–14.
  12. Hecksel K.A., Bostwick J.M., Jaeger T.M., Cha S.S. Inappropriate use of symptom-triggered therapy for alcohol withdrawal in the general hospital. Mayo Clin Proc 2008; 83:274–279.
  13. Makdissi R., Stewart S.H. Care for hospitalized patients with unhealthy alcohol use: a narrative review. Addiction Science & Clinical Practice 2013; 8:11.
  14. Sarff M., Gold J.A. Alcohol withdrawal syndromes in the intensive care unit. Crit Care Med. 2010; 38:494-501.
  15. National Institute on Alcohol Abuse and Alcoholism: Helping patients who drink too much: A clinician's guide. US Department of Health and Human Services, 2005.
  16. National Institute on Alcohol Abuse and Alcoholism: Helping patients who drink too much: A clinician's guide. US Department of Health and Human Services, 2007
  17. Dawson D.A., Grant B.F., Li T.K. Surgeon General releases advisory on alcohol use in pregnancy (press release). Washington, DC. U.S. Department of Health and Human Services. February 21, 2005. Available at: http://www.surgeongeneral.gov/pressreleases/sg02222005.html. Accessed October 3, 2006.
  18. Dawson D.A., Grant B.F., Li T.K. Quantifying the risks associated with exceeding recommended drinking limits. Alcohol Clin Exp Res., 2005; 29 (5):902-908.
  19. U.S. Surgeon General releases advisory on alcohol use in pregnancy [press release]. Washington, DC. U.S. Department of Health and Human Services. February 21, 2005. Available at: http://www.surgeongeneral.gov/pressreleases/sg02222005.html. Accessed October 3, 2006.
  20. Brown L.A., Cook R.T., Jerrells T.R., Kolls J.K., Nagy L.E., Szabo G., Wands J.R., Kovacs E.J. Acute and chronic alcohol abuse modulate immunity. Alcohol Clin Exp Res 2006; 30:1624–1631.
  21. Bradley K.A., De Benedetti A.F., Volk R.J., Williams E.C., Frank D., Kivlahan D.R. AUDIT-C as a brief screen for alcohol misuse in primary care. Alcohol Clin Exp Res 2007; 31:1208–1217.
  22. Smith P.C., Schmidt S.M., Allensworth-Davies D., Saitz R. Primary care validation of a single-question alcohol screening test. J Gen Intern Med 2009; 24:783–788.
  23. Sorensen L.T., Jorgensen T., Kirkeby L.T., Skovdal J., Venntis B., Willie-Jorgensen P. Smoking and alcohol abuse are major risk factors for anastomotic leakage in colorectal surgery. Br J Surg. 1999; 86:927-31.
  24. Kosten T.R., O’Connor P.G. Management of drug and alcohol withdrawal. N Engl J Med 2003; 348:1786.
  25. Doering P.L., Li R. Substance-related disorders: alcohol, nicotine, and caffeine. In: DiPiro J.T., Talbert R.L., Yee G.C., Matzke G.R., Wells B.G., Posey L. eds. Pharmacotherapy: A Pathophysiologic Approach. 8th ed. New York, NY: McGraw-Hill; 2011:chap 75. Accessed December 22, 2014.
  26. Cravo M.L., Gloria L.M., Selhub J. et al. Hyperhomocysteinemia in chronic alcoholism: correlation with folate, vitamin B-12, and vitamin B-6 status. Am J Clin Nutr. 1996; 63:220-224.
  27. Latt N., Dore G. Thiamine in the treatment of Wernicke encephalopathy in patients with alcohol use disorders. Intern Med J. 2014; 44:911-915.
  28. Mayo-Smith M.F. Pharmacological management of alcohol withdrawal. A meta-analysis and evidence-based practice guideline. American Society of Addiction Medicine Working Group on Pharmacological Management of Alcohol Withdrawal. JAMA 1997; 278:144–151.
  29. Spies C.D., Rommelspacher H. Alcohol withdrawal in the surgical patient: Prevention and treatment. Anesth Analg 1999; 88:946–954.
  30. Guthrie S.K., Augustin S.G. Anxiety disorders. In: Young L.Y., Kradjan W.A., Guglielmo J., Alldredge B.K., Koda-Kimble M.A. (Eds.), Applied Therapeutics: The Clinical Use of Drugs. Wolsters Kluwer and Lippincott Williams & Wilkins,New York 2008; p. 2137.
  31. Spies C., Tшnnesen H., Andreasson S., Helander A., Conigrave K. Perioperative morbidity and mortality in chronic alcoholic patients. Alcoholism 2001; 25(5):164–170.
  32. Sullivan J.T., Sykora K., Schneiderman J., Naranjo C.A., Sellers E.M. Assessment of alcohol withdrawal: the revised clinical institute withdrawal assessment for alcohol scale (CIWA-Ar). British Journal of Addiction 1989; 84(11):1353–1357.
  33. Spies C.D., von Dossow V., Eggers V., Jetschmann G., El-Hilali R., Egert J., Fischer M., Schroder T., Hoflich C., Sinha P. et al: Altered cell-mediated immunity and increased postoperative infection rate in long-term alcoholic patients. Anesthesiology 2004, 100:1088–1100.
  34. Spies C., Eggers V., Szabo G., Lau A., von Dossow V., Schoenfeld H., Althoff H., Hegenscheid K., Bohm B., Schroeder T., Pfeiffer S., Ziemer S., Paschen C., Klein M., Marks C., Miller P., Sander M., Wernecke K.D., Achterberg E., Kaisers U., Volk H.D. Intervention at the level of the neuroendocrine-immune axis and postoperative pneumonia rate in long-term alcoholics. Am J Respir Crit Care Med 2006; 174:408–14.
  35. Brunton L., Chabner B., Knollmann B., eds. Goodman and Gilman’s The Pharmacological Basis of Therapeutics. 12th ed. New York, NY: McGraw-Hill; 2011.
  36. «Клинические рекомендации по диагностике и лечению алкогольной зависимости» Российского общества психиатров (2019 г).
  37. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 5th ed. Washington, DC: American Psychiatric Association; 2013.
  38. Schuckit M.A. Recognition and management of withdrawal delirium (delirium tremens). N Engl J Med. 2014; 371:2109-2113.
  39. Mayfield D., McLeod G., Hall P. The CAGE Questionnaire: Validation of a New Alcoholism Screening Instrument. AmJ Psychiatry. 1974; 131.10:1121-1123.
  40. Fiellin D.A., Reid M.C., O'Connor P.G. Screening for alcohol problems in primary care: a systematic review. Arch Intern Med 2000, 160:1977–1989.
  41. Choe Y.M., Lee B.C., Choi I.G., Suh G.H., Lee D.Y., .Kim J.W. Combination of the CAGE and serum gamma-glutamyl transferase: an effective screening tool for alcohol use disorder and alcohol dependence //Neuropsychiatr Dis Treat. 2019; 15: 1507–1515.
  42. Eliasen M., Grønkjær M., Skov-Ettrup L.S., Mikkelsen S.S., Becker U., Tolstrup J.S., Flensborg-Madsen T. Preoperative alcohol consumption and postoperative complications: a systematic review and meta-analysis. // Ann Surg. 2013 Dec;258(6):930-42.
  43. Bayard M., McIntyre J., Hill K.R., Woodside J.Jr. Alcohol withdrawal syndrome. Am Fam Physician 2004; 69(60):1443–50.
  44. Muzyk A.J., Kerns S., Brudney S., Gagliardi J.P. Dexmedetomidine for the treatment of alcohol withdrawal syndrome: rationale and current status of research. CNS Drugs 2013; 27(11):913–20.
  45. Linn D.D., Loeser K.C. Dexmedetomidine for alcohol withdrawal syndrome: a review of the literature. Ann Pharmacother 2015; 49(12):1336–42. doi:0.1177/1060028015607038.
  46. Awissi D-K., Lebrun G., Fagnan M., Skrobik Y. Alcohol, nicotine, and iatrogenic withdrawals in the ICU. Crit Care Med. 2013; 41:57-68.
  47. VanderWeide L.A., Foster C.J., MacLaren R., Kiser T.H., Fish D.N., Mueller S.W. Evaluation of early dexmedetomidine addition to the standard of care for severe alcohol withdrawal in the ICU: a retrospective controlled cohort study [published online October 16, 2014]. J Intensive Care Med. doi:10.1177/0885066614554908.
  48. Mueller S.W., Preslaski C.R., Kiser T.H. et al. A randomized, double-blind, placebo-controlled dose range study of dexmedetomidine as adjunctive therapy for alcohol withdrawal. Crit Care Med. 2014; 42:1131-1139.
  49. Gold J.A., Rimal B., Nolan A., Nelson L.S. A strategy of escalating doses of benzodiazepines and phenobarbital administration reduces the need for mechanical ventilation in delirium tremens. Crit Care Med. 2007; 35:724-730.
  50. Wong A., Benedict N.J., Lohr B.R., Pizon A.F., Kane-Gill S.L. Management of benzodiazepine-resistant alcohol withdrawal across a healthcare system: benzodiazepine dose-escalation with or without propofol. Drug Alcohol Depend. 2015; 154:296-299.
  51. Pribek IK, Kovacs I, Kadar BK, et al. Evaluation of the course and treatment of Alcohol Withdrawal Syndrome with the Clinical Institute Withdrawal Assessment for Alcohol - Revised: A systematic review-based meta-analysis. Drug Alcohol Depend. 2021;220:108536. doi:10.1016/j.drugalcdep.2021.108536
  52. Schmidt K.J., Doshi M.R., Holzhausen J.M., Natavio A., Cadiz M., Winegardner J.E. Treatment of Severe Alcohol Withdrawal. Annals of Pharmacotherapy 2016; Vol. 50(5):389–401.
  53. Tonnesen H., Kehlet H. Preoperative alcoholism and postoperative morbidity. Br J Surg. 1999b Jul;86(7):869-74. doi: 10.1046/j.1365-2168.1999.01181.x
  54. Palmer B.F., Clegg D.J. Electrolyte Disturbances in Patients with Chronic Alcohol-Use Disorder. N Engl J Med. 2017 Oct 5;377(14):1368-1377. doi: 10.1056/NEJMra1704724
  55. Oppedal K., Møller A.M., Pedersen B., Tønnesen H. Preoperative alcohol cessation prior to elective surgery. Cochrane Database Syst Rev. 2012 Jul 11;(7):CD008343. doi: 10.1002/14651858.CD008343.pub2.
  56. Solorzano G.E., Guha R. Wernicke's encephalopathy: under our radar more than it should be? Pract Gastroenterol 2016; 40(2): 30-6.
  57. Wrenn K.D., Slovis C.M., Minion G.E., Rutkowski R. The syndrome of alcoholic ketoacidosis. Am J Med. 1991 Aug;91(2):119-28. doi: 10.1016/0002-9343(91)90003-g
  58. Yip L. Ethanol. In: Nelson L., Lewin N., Howland M., Hoffman R., Goldfrank L., Fomenbaum N., eds. Goldfrank’s Toxicologic Emergencies. 9th ed. New York, NY: McGraw-Hill; 2011. http://0-accesspharmacy.mhmedical.com.libcat.ferris.edu/content.aspx?. Accessed December 18, 2014.
  59. Goodson CM, Clark BJ, Douglas IS. Predictors of severe alcohol withdrawal syndrome: a systematic review and meta-analysis. Alcohol Clin Exp Res. 2014;38(10):2664-2677. doi:10.1111/acer.12529
  60. Mayo-Smith M.F., Bernard D. Late-onset seizures in alcohol withdrawal. Alcohol Clin Exp Res 1995; 19:656–9.
  61. Holbrook A.M., Crowther R., Lotter A., Cheng C., King D. Meta-analysis of benzodiazepine use in the treatment of acute alcohol withdrawal. CMAJ 1999; 160:649–55.
  62. Lejoyeux M., Solomon J., Ades J. Benzodiazepine treatment for alcohol-dependent patients. Alcohol Alcohol 1998; 33(6):563–75.
  63. Amato L., Minozzi S., Vecchi S., Davoli M. Benzodiazepines for alcohol withdrawal. Cochrane Database Syst Rev 2010; 17(3): CD005063.
  64. Katzung B., Trevor A., eds. Basic and Clinical Pharmacology. 13th ed. New York, NY: McGraw-Hill; 2015.
  65. Daeppen J.B., Gache P., Landry U. et al. Symptom-triggered vs fixed-schedule doses of benzodiazepine for alcohol withdrawal. Arch Intern Med. 2002;.162:1117-1121.
  66. Saitz R., Mayo-Smith M.F., Roberts M.S., Redmond H.A., Bernard D.R., Calkins D.R. Individualized treatment for alcohol withdrawal: a randomized double-blind controlled trial. JAMA. 1994; 272:519-523.
  67. Spies C.D., Otter H.E., H€uske B., Sinha P., Neumann T., Rettig J. Alcohol withdrawal severity is decreased by symptom-orientated adjusted bolus therapy in the ICU. Intensive Care Med 2003; 29:2230.
  68. Jaeger T.M., Lohr R.H., Pankratz V.S. Symptom-triggered therapy for alcohol withdrawal syndrome in medical inpatients. Mayo Clin Proc 2001; 76:695.
  69. Cassidy E.M., O’Sullivan I., Bradshaw P., Islam T., Onovo C. Symptom-triggered benzodiazepine therapy for alcohol withdrawal syndrome in the emergency department: a comparison with the standard fixed dose benzodiazepine regimen. Emerg Med J 2012; 29(10):802–4.
  70. Holleck J.L., Merchant N., Gunderson C.G. Symptom-Triggered Therapy for Alcohol Withdrawal Syndrome: a Systematic Review and Meta-analysis of Randomized Controlled Trial // J Gen Intern Med. 2019 Jun;34(6):1018-1024
  71. Kattimani S., Bharadwaj B. Clinical management of alcohol withdrawal: a systemic review. Ind Psychiatry J 2013; 22(2):100–8.
  72. Foy A., McKay S., Ling S., Bertram M., Sadler C. Clinical use of a shortened alcohol withdrawal scale in a general hospital. Intern Med J 2006, 36:150–154.
  73. Reoux J.P., Oreskovich M.R. A comparison of two versions of the clinical institute withdrawal assessment for alcohol: the CIWA-Ar and CIWA-AD. Am J Addict 2006, 15:85–93.
  74. Detoxification and substance abuse treatment. In Treatment improvement protocol 45. Edited by Miller N.S., Kipnis S.S. Rockville M.D. Substance Abuse and Mental Health Services Administration. DHHS publication no; 2006. 06–4131. Available at http://www.ncbi.nlm.nih.gov/books/NBK64115/pdf/TOC.pdf.
  75. Wasilewski D., Matsumoto H., Kur E. et al. Assessment of diazepam loading dose therapy of delirium tremens. Alcohol Alcohol. 1996;.31:273-278.
  76. Hack J.B., Hoffmann R.S., Nelson L.S. Resistant alcohol withdrawal: does an unexpectedly large sedative requirement identify these patients early? J Med Toxicol 2006; 2(2):55–60.
  77. Sohraby R., Attridge R.L., Hughes D.W. Use of propofol-containing versus benzodiazepine regimens for alcohol withdrawal requiring mechanical ventilation. Ann Pharmacother 2014; 48 (4):456–61.
  78. DeMuro J.P., Botros D.G., Wirkowski E., Hanna A.F. Use of dexmedetomidine for the treatment of alcohol withdrawal syndrome in critically ill patients: a retrospective case series. J Anesth 2012; 26(4):601–5.
  79. Johnson M.T., Yamanaka T.T., Fraidenburg D.R., Kane S.P. Benzodiazepine misadventure in acute alcohol withdrawal: the transition from delirium tremens to ICU delirium. J Anesth 2013; 27(1):135– 6.
  80. Rosenson J., Clements .C, Simon B. et al. Phenobarbital for acute alcohol withdrawal: a prospective randomized double-blind placebo-controlled study. J Emerg Med. 2013; 4:592-598.e2.
  81. Oks M, Cleven KL, Healy L, et al. The Safety and Utility of Phenobarbital Use for the Treatment of Severe Alcohol Withdrawal Syndrome in the Medical Intensive Care Unit. J Intensive Care Med. 2020;35(9):844-850. doi:10.1177/0885066618783947
  82. Mayo-Smith M.F., Beecher L.H., Fischer T.L., Gorelick D.A., Guillaume J.L., Hill A., Jara G., Kasser C., Melbourne J. Management of alcohol withdrawal delirium. An evidence-based practice guideline. Archives of Internal Medicine 2004, 164:1405–1412.
  83. Duby J.J., Berry A.J., Ghayyem P., Wilson M.D., Cocanour C.S. Alcohol withdrawal syndrome in critically ill patients: Protocolized versus nonprotocolized management. J Trauma Acute Care Surg. 2014; 77:938-943.
  84. Brotherton A.L., Hamilton E.P., Kloss H.G., Hammond D.A. Propofol for Treatment of Refractory Alcohol Withdrawal Syndrome: A Review of the Literature. Pharmacotherapy 2016; 36(4):433–442.
  85. Michaelsen I.H., Anderson J.E., Fink-Jensen A., Allerup P., Ulrichsen J. Phenobarbital versus diazepam for delirium tremens: a retrospective study. Dan Med Bull. 2010; 57:A4169.
  86. Hayner C.E., Wuestefeld N.L., Bolton P.J. Phenobarbital treatment in a patient with resistant alcohol withdrawal syndrome. Pharmacotherapy 2009; 29:875-878.
  87. Hjermo I., Anderson J.E., Fink-Jensen A., Allerup P., Ulrichsen J. Phenobarbital versus diazepam for delirium tremens – a retrospective study. Dan Med Bull 2010; 57(8):A4169.
  88. Wong A., Benedict N.J., Kane-Gill S.L. Multicenter evaluation of pharmacologic management and outcomes associated with severe resistant alcohol withdrawal. J Crit Care 2015; 30 (2):405–9.
  89. Coomes T.R., Smith S.W. Successful use of propofol in refractory delirium tremens. Ann Emerg Med. 1997; 30:825-828.
  90. McCowan C., Marik P. Refractory delirium tremens treated with propofol: a case series. Crit Care Med. 2000; 28:1781-1784.
  91. Mahajan R., Singh R., Bansal P., Bala R. Use of propofol as adjuvant therapy in refractory delirium tremens. Ind Psychiatry J. 2010; 19:58-59.
  92. Hughes D.W., Vanwert E., Lepori L., Adams B.D. Propofol for benzodiazepine-refractory alcohol withdrawal in a non-mechanically ventilated patient. Am J Emerg Med. 2014; 32:112.e3-112.e4.
  93. Lorentzen K., Lauritsen A.Ø., Bendtsen A.O. Use of propofol infusion in alcohol withdrawal-induced refractory delirium tremens. Dan Med J 2014; 61(5):A4807.
  94. Hoffman P.L., Grant K.A., Snell L.D., Reinlib L., Lorio K., Tabakoff B. NMDA receptors: role in ethanol withdrawal seizures. Ann N Y Acad Sci 1992; 654:52.
  95. Marik P.E. Propofol: therapeutic indications and side-effects. Curr Pharm Des 2004; 10:3639–49.
  96. Liang, J., Spigelman I., Olsen R.W. Tolerance to sedative/hypnotic actions of GABAergic drugs correlates with tolerance to potentiation of extrasynaptictonic currents of alcohol-dependent rats. J. Neurophysiol. 2009. 102, 224–233.
  97. Barr J., Fraser G.L., Puntillo K. et al. Clinical practice guidelines for the management of pain, agitation, and delirium in adult patients in the intensive care unit. Crit Care Med. 2013; 41:278-280.
  98. Takeshita J. Use of propofol for alcohol withdrawal delirium: a case report. J Clin Psychiatry 2004; 65(1):134–5.
  99. Subramaniam K., Gowda R.M., Jani K., Zewedie W., Ute R. Propofol combined with lorazepam for severe poly substance misuse and withdrawal states in the intensive care unit: a case series and review. J Emerg Med 2004; 21:632–4.
  100. Lizotte R.J., Kappes J.A., Bartel B.J., Hayes K.M., Lesselyoung V.L. Evaluating the effects of dexmedetomidine compared to propofol as adjunctive therapy in patients with alcohol withdrawal. Clin Pharmacol 2014 ;6:171–7.
  101. Ludtke K.A., Stanley K.S., Yount N.L., Gerkin R.D. Retrospective Review of Critically Ill Patients Experiencing Alcohol Withdrawal: Dexmedetomidine Versus Propofol and/or Lorazepam Continuous Infusions. Hosp Pharm 2015; 50(3):208–13.
  102. DeCarolis D.D., Rice K.L., Ho L., Willenbring M.L., Cassaro S. Symptom-driven lorazepam protocol for treatment of severe alcohol withdrawal delirium in the intensive care unit. Pharmacotherapy. 2007; 27:510-518.
  103. Gallimberti L., Canton G., Gentile N., Ferri M., Cibin M., Ferrara S.D., Fadda F., Gessa G.L. Gamma-hydroxybutyric acid for treatment of alcohol withdrawal syndrome. // Lancet. 1989 Sep 30;2(8666):787-9.
  104. Leone M.A., Vigna-Taglianti F., Avanzi G., Brambilla R., Faggiano F. Gamma-hydroxybutyrate (GHB) for treatment of alcohol withdrawal and prevention of relapses. // Cochrane Database Syst Rev. 2010 Feb 17;(2):CD006266. doi: 10.1002/14651858.CD006266.pub2.
  105. Addolorato G., Balducci G., Capristo E., Attilia M.L., Taggi F., Gasbarrini G., Ceccanti M. Gamma-hydroxybutyric acid (GHB) in the treatment of alcohol withdrawal syndrome: a randomized comparative study versus benzodiazepine. // Alcohol Clin Exp Res. 1999 Oct;23(10):1596-604.
  106. Lenzenhuber E., Müller C., Rommelspacher H., Spies C. Gamma-hydroxybutyrate for treatment of alcohol withdrawal syndrome in intensive care patients. A comparison between with two symptom-oriented therapeutic concepts. // Anaesthesist. 1999 Feb;48(2):89-96.
  107. Elsing C., Stremmel W., Grenda U., Herrmann T. Gamma-hydroxybutyric acid versus clomethiazole for the treatment of alcohol withdrawal syndrome in a medical intensive care unit: an open, single-center randomized study. // Am J Drug Alcohol Abuse. 2009;35(3):189-92. doi: 10.1080/00952990902933852.
  108. Vagts D.A., Iber T., Nöldge-Schomburg G.F. Alcohol-a perioperative problem of anaesthesia and intensive care medicine. // Anasthesiol Intensivmed Notfallmed Schmerzther. 2003 Dec;38(12):747- 61.
  109. Leung J.G., Hall-Flavin D., Nelson S., Schmidt K.A., Schak K.M. The role of gabapentin in the management of alcohol withdrawal and dependence. // Ann Pharmacother. 2015 Aug;49(8):897-906.
  110. Myrick H., Malcolm R., Randall P.K., Boyle E., Anton R.F., Becker H.C., Randall C.L. A double-blind trial of gabapentin versus lorazepam in the treatment of alcohol withdrawal. // Alcohol Clin Exp Res. 2009 Sep;33(9):1582-8.
  111. Stock C.J., Carpenter L., Ying J., Greene T. Gabapentin versus chlordiazepoxide for outpatient alcohol detoxification treatment. // Ann Pharmacother. 2013 Jul-Aug;47(7-8):961-9.
  112. Andaluz A., DeMoss D., Claassen C., Blair S., Hsu J., Bakre S., Khan M., Atem F., Rush A.J. Fixed-dose gabapentin augmentation in the treatment of alcohol withdrawal syndrome: a retrospective, open-label study. // Am J Drug Alcohol Abuse. 2019 Sep 6:1-9.
  113. Bonnet U., Hamzavi-Abedi R., Specka M., Wiltfang J., Lieb B., Scherbaum N. An open trial of gabapentin in acute alcohol withdrawal using an oral loading protocol. // Alcohol Alcohol. 2010 Mar-Apr;45(2):143-5.
  114. Mariani J.J., Rosenthal R.N., Tross S., Singh P., Anand O.P. A randomized, open-label, controlled trial of gabapentin and phenobarbital in the treatment of alcohol withdrawal. // Am J Addict. 2006 Jan-Feb;15(1):76-84.
  115. Levine A.R., Carrasquillo L., Mueller J., Nounou M.I., Naut E.R., Ibrahim D. High-Dose Gabapentin for the Treatment of Severe Alcohol Withdrawal Syndrome: A Retrospective Cohort Analysis. // Pharmacotherapy. 2019 Sep;39(9):881-888.
  116. Wilming C., Alford M., Klaus L. Gabapentin Use in Acute Alcohol Withdrawal Management. // Fed Pract. 2018 Mar;35(3):40-46.
  117. Nichols T.A., Robert S., Taber D.J., Cluver J. Alcohol withdrawal-related outcomes associated with gabapentin use in an inpatient psychiatric facility. // Ment Health Clin [Internet]. 2019;9(1):1-5.
  118. Vadiei N., Smith T.L., Walton A.E., Kjome K.L. Impact of Gabapentin Adjunct use with Benzodiazepines for the Treatment of Alcohol Withdrawal in a Psychiatric Hospital. // Psychopharmacol Bull. 2019 Feb 15;49(1):17-27.
  119. Minozzi S., Amato L., Vecchi S., Davoli M. Anticonvulsants for alcohol withdrawal. Cochrane Database Syst Rev 2010: CD005064.
  120. Lai JY, Kalk N, Roberts E. The effectiveness and tolerability of anti-seizure medication in alcohol withdrawal syndrome: a systematic review, meta-analysis and GRADE of the evidence [published online ahead of print, 2021 Apr 6]. Addiction. 2021;10.1111/add.15510. doi:10.1111/add.15510
  121. Palestine M.L., Alatorre E. Control of acute alcoholic withdrawal symptoms: a comparative study of haloperidol and chlordiazepoxide. Curr Ther Res Clin Exp 1976; 20(3):289–99.
  122. Crispo A.L., Daley M.J., Pepin J.L., Harford P.H., Brown C.V.R. Comparison of clinical outcomes in nonintubated patients with severe alcohol withdrawal syndrome treated with continuous-infusion sedatives: dexmedetomidine versus benzodiazepines. Pharmacotherapy. 2014; 34:910-917.
  123. Baddigam K., Russo P., Russo J., Tobias J. Dexmedetomidine in the treatment of withdrawal syndromes in cardiothoracic surgery patients. J Intensive Care Med. 2005; 20:118-123.
  124. Rovasalo A., Tohmo H., Aantaa R., Kettunen E., Palojoki R. Dexmedetomidine as an adjuvant in the treatment of alcohol withdrawal delirium: a case report. Gen Hosp Psychiatry. 2006; 28:362-363.
  125. Darrouj J., Puri N., Prince E., Lomonaco A., Spevetz A., Gerber D.R. Dexmedetomidine infusion as adjunctive therapy to benzodiazepines for acute alcohol withdrawal. Ann Pharmacother. 2008; 42:1703-1705.
  126. Muzyk A., Revollo J., Rivelli S. The use of dexmedetomidine in alcohol withdrawal. J Neuropsychiatry Clin Neurosci. 2012; 24:45-46.
  127. Tolonen J., Rossinen J., Alho H., Harjola V.P. Dexmedetomidine in addition to benzodiazepine-based sedation in patients with alcohol withdrawal delirium. Eur J Emerg Med. 2013; 20:425-427.
  128. Rayner S., Weinert C., Peng H., Jepsen S., Broccard A. A study institution. Dexmedetomidine as adjunct treatment for severe alcohol withdrawal in the ICU. Ann Intensive Care 2012; 2:12.
  129. Love K, Zimmermann AE. Use of Propofol Plus Dexmedetomidine in Patients Experiencing Severe Alcohol Withdrawal in the Intensive Care Unit. J Clin Pharmacol. 2020;60(4):439-443. doi:10.1002/jcph.1539
  130. Riker R.R., Shehabi Y., Bokesch P.M. et al. Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial. JAMA 2009; 301:489-499.
  131. Pandharipande P.P., Sanders R.D., Girard T.D. et al. Effect of dexmedetomidine versus lorazepam on outcome in patients with sepsis: an a priori-designed analysis of the MENDS randomized controlled trial. Crit Care. 2010; 14:R38.
  132. Jones G.M., Murphy C.V., Gerlach A.T., Goodman E.M., Pell L.J. High-dose dexmedetomidine for sedation in the intensive care unit: an evaluation of clinical efficacy and safety. Ann Pharmacother. 2011; 45:740-747.
  133. Zilm D.H., Jacob M.S., MacLeod S.M., Sellers E.M., Ti T.Y. Propranolol and chlordiazepoxide effects on cardiac arrhythmias during alcohol withdrawal. Alcohol Clin Exp Res 1980; 4:400–5.
  134. Worner T.M. Propranolol versus diazepam in the management of the alcohol withdrawal syndrome: double-blind controlled trial. Am J Drug Alcohol Abuse 1994; 20:115–24.
  135. Weinberg J.A., Magnotti L.J., Fischer P.E., Edwards N.M., Schroeppel T., Fabian T.C., Croce M.A: Comparison of intravenous ethanol versus diazepam for alcohol withdrawal prophylaxis in the trauma ICU: results of a randomized trial. J Trauma 2008, 64:99–104.
  136. Eggers V., Tio J., Neumann T., Pragst F., Muller C., Schmidt L.G., Kox W.J., Spies C.D. Blood alcohol concentration for monitoring ethanol treatment to prevent alcohol withdrawal in the intensive care unit. Intensive Care Med 2002, 28:1475–1482.
  137. Hodges B., Mazur J.E: Intravenous ethanol for the treatment of alcohol withdrawal syndrome in critically ill patients. Pharmacotherapy 2004, 24:1578–1585.
  138. Egholm J.W., Pedersen B., Møller A.M., Adami J., Juhl C.B., Tønnesen H. Perioperative alcohol cessation intervention for postoperative complications. Cochrane Database Syst Rev. 2018 Nov 8;11:CD008343. doi: 10.1002/14651858.CD008343.pub3.
  139. Hansen T.B., Bredtoft H.K., Larsen K. Preoperative Physical Optimization in Fast-Track Hip and Knee Arthroplasty. Dan Med J. 2012 Feb;59(2):A4381. PMID: 22293051
  140. Lowery E.M., Yong M., Cohen A., Joyce C., Kovacs E.J. Recent alcohol use prolongs hospital length of stay following lung transplant. Clin Transplant. 2018 Jun;32(6):e13250. doi: 10.1111/ctr.13250.
  141. Budworth L., Prestwich A., Lawton R., Kotzé A., Kellar I. Preoperative Interventions for Alcohol and Other Recreational Substance Use: A Systematic Review and Meta-Analysis. Front Psychol. 2019 Feb 4;10:34. doi: 10.3389/fpsyg.2019.00034.
  142. Tønnesen H., Rosenberg J., Nielsen H.J., Rasmussen V., Hauge C., Pedersen I.K., Kehlet H. Effect of preoperative abstinence on poor postoperative outcome in alcohol misusers: Randomised controlled trial. BMJ 1999; 318:1311–1316.
  143. Tonnesen H. Alcohol abuse and postoperative morbidity. Dan Med Bull 2003;50:139–60. PMID: 12812138
  144. Tonnesen H., Nielsen P.R., Lauritzen J.B., Moller A.M. Smoking and alcohol intervention before surgery: evidence for best practice. Br J Anaesth 2009;102:297–306. doi: 10.1093/bja/aen401.
  145. Tønnesen H. Influence of alcohol on several physiological functions and its reversibility: A surgical view. Acta Psychiatr Scand 1992; 86:67–71.
  146. Tønnesen H., Kaiser A.H., Nielsen B.B., Pedersen A.E. Reversibility of alcohol-induced immune depression. Br J Addict 1992; 87:1025–1028.
  147. Rubinsky A.D., Bishop M.J., Maynard C., Henderson W.G., Hawn M.T., Harris A.H.S., Lauren A., Beste L.A., Tønnesen H., Bradley K.A. Postoperative Risks Associated With Alcohol Screening Depend on Documented Drinking at the Time of Surgery. Drug Alcohol Depend. 2013 Oct 1;132(3):521-7. doi: 10.1016/j.drugalcdep.2013.03.022.
  148. Shourie S., Conigrave K.M., Proude E.M., Ward J.E., Wutzke S.E., Haber P.S. The Effectiveness of a Tailored Intervention for Excessive Alcohol Consumption Prior to Elective Surgery. Alcohol Alcohol. Nov-Dec 2006;41(6):643-9. doi: 10.1093/alcalc/agl059.
  149. Kelbæk H., Nielsen B.M., Eriksen J., Rabol A., Christensen N.J., Lund J.O., Bonnevie O., Munck O., Godtfredsen J. Left ventricular performance in alcoholic patients without chronic liver disease. Br Heart J 1987; 58:352–357
  150. Ehrenreich H., Schuck J., Stender N., Pilz J., Gefeller O., Schilling L., Poser W., Kaw S. Endocrine and hemodynamic effects of stress versus systemic CRF in alcoholics during early and medium term abstinence. Alcohol Clin Exp Res 1997; 21:1285–1293
  151. Coiro V., Casti A., Jotti G.S., Rubino P., Manfredi G., Maffei M.L., Melani A., Volta E., Chiodera P. Adrenocorticotropic Hormone/Cortisol Response to Physical Exercise in Abstinent Alcoholic Patients. Alcohol Clin Exp Res. 2007 May;31(5):901-6. doi: 10.1111/j.1530-0277.2007.00376.x
  152. De Marchi S, Cecchin E, Basile A, Bertotti A, Nardini R, Bartoli E. Renal tubular dysfunction in chronic alcohol abuse - effects of abstinence. N Engl J Med 1993; 329: 1927-34. doi: 10.1056/NEJM199312233292605
  153. Fernandez A.C., Claborn K.R., Borsari B. A systematic review of behavioural interventions to reduce preoperative alcohol use. Drug Alcohol Rev. 2015 Sep;34(5):508-520. doi: 10.1111/dar.12285
  154. Bradley A.D., Rubinsky A.D., Sun H., Blough D.K., Tønnesen H., Hughes G., Beste L.A., Bishop M.J., Hawn M.T., Maynard C., Harris A.S.H., Hawkins E.J., Bryson C.L., Houston T.K., Henderson W.G., Kivlahan D.R. Prevalence of Alcohol Misuse Among Men and Women Undergoing Major Noncardiac Surgery in the Veterans Affairs Health Care System. Surgery. 2012 Jul;152(1):69-81. doi: 10.1016/j.surg.2012.02.007
  155. Felsenfeld A.J., Levine B.S. Approach to treatment of hypophosphatemia. Am J Kidney Dis 2012; 60: 655-61. doi: 10.1053/j.ajkd.2012.03.024
  156. Kuchly B., Tiksrail A., Baglioni P. Electrolyte Disturbances in Chronic Alcohol-Use Disorder. N Engl J Med. 2018 Jan 11;378(2):203. doi: 10.1056/NEJMc1714331
  157. Palmer B.F., Clegg D.J. Electrolyte Disturbances in Chronic Alcohol-Use Disorder. N Engl J Med. 2018 Jan 11;378(2):203-204. doi: 10.1056/NEJMc1714331
  158. Broeren M.A., Geerdink E.A., Vader H.L., van den Wall Bake A.W. Hypomagnesemia induced by several proton-pump inhibitors. Ann Intern Med 2009; 151: 755-6. doi: 10.7326/0003-4819-151-10-200911170-00016
  159. Park CH, Kim EH, Roh YH, Kim HY, Lee SK. The association between the use of proton pump inhibitors and the risk of hypomagnesemia: a systematic review and meta-analysis. PLoS One 2014; 9(11): e112558. doi: 10.1371/journal.pone.0112558
  160. Cheungpasitporn W., Thongprayoon C., Kittanamongkolchai W., Srivali N., Edmonds P.J., Ungprasert P., O'Corragain O.A., Korpaisarn S., Erickson S.B. Proton pump inhibitors linked to hypomagnesemia: a systematic review and meta-analysis of observational studies. Ren Fail 2015; 37: 1237-41. doi: 10.3109/0886022X.2015.1057800
  161. FDA drug safety communication: low magnesium levels can be associated with long-term use of Proton Pump Inhibitor drugs (PPIs). Silver Spring, MD: Food and Drug Administration, March 2, 2011 (http://www.fda.gov/drugs/drugsafety/ucm245011.htm)
  162. Palmer BF. Diagnostic approach and management of inpatient hyponatremia. J Hosp Med 2010; 5: Suppl 3: S1-S7. doi: 10.1002/jhm.702
  163. Achinger S.G., Ayus J.C. Electrolyte Disturbances in Chronic Alcohol-Use Disorder. N Engl J Med. 2018 Jan 11;378(2):202-3. doi: 10.1056/NEJMc1714331
  164. Sterns R.H., Silver S.M. Complications and management of hyponatremia. Curr Opin Nephrol Hypertens 2016; 25: 114-9. doi: 10.1097/MNH.0000000000000200
  165. Sanghvi S.R., Kellerman P.S., Nanovic L. Beer potomania: an unusual cause of hyponatremia at high risk of complications from rapid correction. Am J Kidney Dis 2007; 50: 673-80. doi: 10.1053/j.ajkd.2007.07.015
  166. Bähr M, Sommer N, Petersen D, Wiethölter H, Dichgans J. Central pontine myelinolysis associated with low potassium levels in alcoholism. J Neurol 1990; 237: 275-6. doi: 10.1007/BF00314635
  167. Falcone N, Compagnoni A, Meschini C, Perrone C, Nappo A. Central pontine myelinolysis induced by hypophosphatemia following Wernicke’s encephalopathy. Neurol Sci 2004; 24: 407-10. Neurol Sci. 2004 Feb;24(6):407-10. doi: 10.1007/s10072-003-0197-9
  168. Ayus J.C., Armstrong D., Arieff A.I. Hyponatremia with hypoxia: effects on brain adaptation, perfusion, and histology in rodents. Kidney Int 2006; 69: 1319-25. doi: 10.1038/sj.ki.5000187
  169. Sterns RH. Disorders of plasma sodium — causes, consequences, and correction. N Engl J Med 2015; 372: 55-65. doi: 10.1056/NEJMra1404489

Для продолжения работы требуется Registration
На предыдущую страницу

Предыдущая страница

Следующая страница

На следующую страницу
Список литературы
На предыдущую главу Предыдущая глава
оглавление
Следующая глава На следующую главу

Table of contents

Данный блок поддерживает скрол*